The efficacy and safety of anti-Aβ agents for delaying cognitive decline in Alzheimer’s disease: a meta-analysis

BACKGROUND: This meta-analysis evaluates the efficacy and safety of amyloid-β (Aβ) targeted therapies for delaying cognitive deterioration in Alzheimer’s disease (AD). METHODS: PubMed, EMBASE, the Cochrane Library, and ClinicalTrials.gov were systematically searched to identify relevant studies publ...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiaxuan, Wu, Xin, Tan, Xin, Wang, Shixin, Qu, Ruisi, Wu, Xiaofeng, Chen, Zhouqing, Wang, Zhong, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661413/
https://www.ncbi.nlm.nih.gov/pubmed/38020763
http://dx.doi.org/10.3389/fnagi.2023.1257973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661413/
https://www.ncbi.nlm.nih.gov/pubmed/38020763
http://dx.doi.org/10.3389/fnagi.2023.1257973

Ejemplares similares